First in Human Study of TORL-2-307-MAB in Participants With Advanced Cancer
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05159440 |
|
Recruitment Status :
Recruiting
First Posted : December 16, 2021
Last Update Posted : March 6, 2023
|
Sponsor:
TORL Biotherapeutics, LLC
Collaborator:
Translational Research in Oncology
Information provided by (Responsible Party):
TORL Biotherapeutics, LLC
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | December 15, 2024 |
| Estimated Study Completion Date : | December 15, 2025 |